Blog
Clinical
The Clinical Trial Process Continues Amid COVID-19
April 15, 2020
Read Now
Filter by:
All
Regulatory
Bioanalytical
Preclinical
Clinical
Clinical
The Clinical Trial Process Continues Amid COVID-19
April 15, 2020
The Clinical Trial Process Continues Amid COVID-19
Read
Clinical
Technology Challenges and Trends in Clinical Trials
February 3, 2020
Technology Challenges and Trends in Clinical Trials
Read
Preclinical
Maximizing Reproducibility in Cancer Research
November 14, 2019
Maximizing Reproducibility in Cancer Research
Read
Preclinical
Will Your Cancer Drug Move Past Phase 1?
April 18, 2019
Will Your Cancer Drug Move Past Phase 1?
Read
Preclinical
The Missing Step Between Phase I and Phase II
January 28, 2019
The Missing Step Between Phase I and Phase II
Read
Preclinical
Now Available: Liver Fibrosis Models Fed Choline-Deficient, High-Fat Diets
November 26, 2018
Now Available: Liver Fibrosis Models Fed Choline-Deficient, High-Fat Diets
Read
Preclinical
The Keto Diet and Cancer Research: New Insights Emerge
November 7, 2018
The Keto Diet and Cancer Research: New Insights Emerge
Read
Bioanalytical
Early DMPK Analysis Means Opportunity for Better Results
October 25, 2018
Early DMPK Analysis Means Opportunity for Better Results
Read
Preclinical
In Vitro vs. In Vivo Preclinical Drug Testing
October 1, 2018
In Vitro vs. In Vivo Preclinical Drug Testing
Read
Regulatory
Oncology Drug Approval Process
September 18, 2018
Oncology Drug Approval Process
Read
Preclinical
Future Trends for Oncology Drug Development
August 30, 2018
Future Trends for Oncology Drug Development
Read
Clinical
The Top 5 Challenges in Oncology Drug Development
August 20, 2018
The Top 5 Challenges in Oncology Drug Development
Read
Clinical
Your Guide to a Smart Clinical Strategy
June 5, 2018
Your Guide to a Smart Clinical Strategy
Read
Clinical
Move your research forward, smarter with TD2
June 5, 2018
Move your research forward, smarter with TD2
Read
Preclinical
Research Review: 4 Secrets for Preclinical Success
April 25, 2018
Research Review: 4 Secrets for Preclinical Success
Read
Regulatory
What is the Difference Between Research and Commercial IND Categories?
October 1, 2017
What is the Difference Between Research and Commercial IND Categories?
Read
Regulatory
What are the Types of INDs?
September 15, 2017
What are the Types of INDs?
Read
Regulatory
What are the Phases of an IND Investigation?
September 1, 2017
What are the Phases of an IND Investigation?
Read
Preclinical
Who Must Apply for an IND?
August 15, 2017
Who Must Apply for an IND?
Read
Clinical
What is a Clinical Investigation?
August 1, 2017
What is a Clinical Investigation?
Read
Regulatory
What is the Purpose of an IND?
July 15, 2017
What is the Purpose of an IND?
Read
Clinical
Who can Participate in a Clinical Trial?
July 1, 2017
Who can Participate in a Clinical Trial?
Read
Clinical
How can Patients Find Out About a Specific Investigational Drug
June 15, 2017
How can Patients Find Out About a Specific Investigational Drug
Read
Clinical
What are Some of the Potential Drawbacks to Receiving an Investigational Drug?
May 13, 2017
What are Some of the Potential Drawbacks to Receiving an Investigational Drug?
Read
Load More
Recent Resources
Preclinical
The Power of Noninvasive Optical Imaging in Oncology Drug Development
December 7, 2020
Read
Download White Paper
Clinical
Data Insights: Identifying Early Signs of Safety and Efficacy in Oncology Clinical Trials
August 28, 2020
Read
Download White Paper
Clinical
Technology and Next-Generation Oncology Trials
June 22, 2020
Read
Download White Paper
See All
Get free tips, tools and resources by subscribing to the TD2 Newsletter:
Subscribe to TD2 news:
Menu
Home
About Us
+
TD2
Leadership
Services
+
Preclinical
Bioanalytical
Regulatory
Clinical
Partnerships
News & Events
Resources
Blog
Contact
Terms of Use
Privacy Policy
Sitemap
Search for:
13208 E. Shea Blvd, Suite 100,
Scottsdale, AZ 85259
(602) 358-8300
©2019 Translational Drug Development